Chargement en cours...
Secondary Primary Malignancies in Multiple Myeloma: An Old Nemesis Revisited
The treatment of myeloma has undergone extraordinary improvements in the past half century. These advances have been accompanied by a concern for secondary primary malignancies (SPMs). It has been known for decades that extended therapy with alkylating chemotherapy agents, such as melphalan, carries...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Hindawi Publishing Corporation
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3407607/ https://ncbi.nlm.nih.gov/pubmed/22851973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/801495 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|